智通财经APP讯，健倍苗苗(02161)公布截至2026年3月31日止年度业绩，收益约为8.35亿港元，同比增加约6.7%。公司权益持有人应占溢利约2.01亿港元，同比增加约1.9%。每股盈利24.63港仙，末期股息每股7.35港仙。
公告称，收益增长主要受品牌药及品牌中药分部的强劲表现所带动，部分与健康保健品的逊色表现所抵销。在稳固的市场需求及有效的营销措施支持下，品牌药分部收益取得780万港元的增长，反映销售增长势头稳定且促销力度加强，而品牌中药分部收益则增加6290万港元。该等收益部分被健康保健品分部收益减少1840万港元所抵销，主要由于改进产品组合精简化及消费者需求回软所致。三个分部分别占总收益的34%、56%及10%。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.